CLINICAL EFFICACY CHARACTERIZATION OF BENRALIZUMAB FOR PATIENTS WITH NASAL POLYPOSIS AND SEVERE, UNCONTROLLED EOSINOPHILIC ASTHMA

被引：2
|
作者：
Katial, R.
Siddiqui, S.
Barker, P.
Kwiatek, J.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2019年 / 123卷 / 05期
关键词：
D O I：
10.1016/j.anai.2019.08.251
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P109
引用
收藏
页码：S26 / S26
页数：1
相关论文
共 50 条
  • [1] COMPREHENSIVE RESPONSE TO BENRALIZUMAB BY PATIENTS WITH NASAL POLYPOSIS AND SEVERE, EOSINOPHILIC ASTHMA
    Kreindler, J.
    Chanez, P.
    Bourdin, A.
    Burden, A.
    Garcia Gil, E.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S29 - S29
  • [2] Comprehensive Response to Benralizumab by Patients with Nasal Polyposis and Severe, Eosinophilic Asthma
    Kreindler, J.
    Chanez, P.
    Bourdin, A.
    Burden, A.
    Gil, Garcia E. G.
    [J]. PNEUMOLOGIE, 2021, 75 : S34 - S35
  • [3] Efficacy and safety of benralizumab in Japanese patients with severe, uncontrolled eosinophilic asthma
    Ohta, Ken
    Adachi, Mitsuru
    Tohda, Yuji
    Kamei, Tadashi
    Kato, Motokazu
    Fitzgerald, J. Mark
    Takanuma, Masayuki
    Kakuno, Tadahiro
    Imai, Nobuyuki
    Wu, Yanping
    Aurivillius, Magnus
    Goldman, Mitchell
    [J]. ALLERGOLOGY INTERNATIONAL, 2018, 67 (02) : 266 - 272
  • [4] Efficacy and Safety of Benralizumab for Korean Patients With Severe, Uncontrolled Eosinophilic Asthma
    Park, Hae-Sim
    Lee, Sang Haak
    Lee, Sook Young
    Kim, Mi-Kyeong
    Lee, Byung Jae
    Werkstrom, Viktoria
    Barker, Peter
    Zangrilli, James G.
    [J]. ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2019, 11 (04) : 508 - 518
  • [5] Benralizumab improves symptoms of patients with severe, eosinophilic asthma with a diagnosis of nasal polyposis
    Canonica, Giorgio Walter
    Harrison, Tim W.
    Chanez, Pascal
    Menzella, Francesco
    Louis, Renaud
    Cosio, Borja G.
    Lugogo, Njira L.
    Mohan, Arjun
    Burden, Annie
    Gil, Esther Garcia
    [J]. ALLERGY, 2022, 77 (01) : 150 - 161
  • [6] Benralizumab efficacy for patients with fixed airflow obstruction and severe, uncontrolled eosinophilic asthma
    Chipps, Bradley E.
    Hirsch, Ian
    Trudo, Frank
    Alacqua, Marianna
    Zangrilli, James G.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 124 (01) : 79 - 86
  • [7] Evaluation of the effects of Benralizumab on Nasal Inflammation in Severe Eosinophilic Refractory Asthma and Nasal Polyposis
    Candia, Claudio
    Coppa, Francesco
    D'Amato, Maria
    Paris, Debora
    Tramice, Annabella
    Ambrosino, Pasquale
    Molino, Antonio
    Di Stefano, Antonino
    Motta, Andrea
    Maniscalco, Mauro
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [8] Efficacy of Benralizumab in patients with severe eosinophilic asthma
    Soto Hurtado, E.
    Rodriguez Gallego, Y.
    Arzola Rodriguez, M.
    [J]. PNEUMOLOGIE, 2023, 77 : S25 - S26
  • [9] Use of CompEx in eosinophilic patients with severe, uncontrolled asthma on benralizumab
    Bolton, Clare
    Harrison, Tim
    Lugogo, Njira
    Fuhlbrigge, Anne
    Hirsch, Ian
    Bengtsson, Thomas
    Peterson, Stefan
    Sidaway, Martin
    Gil, Esther Garcia
    Fageras, Malin
    Da Silva, Carla A.
    [J]. ERJ OPEN RESEARCH, 2024, 10 (02)
  • [10] Benralizumab efficacy in patients with uncontrolled eosinophilic asthma by age at diagnosis
    Wenzel, Sally
    Brusselle, Guy
    Hirsch, Ian
    Zangrilli, James G.
    Rastogi, Sarang
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
12345